TY - JOUR
KW - co-located care
KW - Harm Reduction
KW - Health services
KW - Hepacivirus
KW - Hepatitis C virus
KW - Hepatitis C/drug therapy/prevention & control
KW - HIV
KW - HIV Infections/drug therapy/prevention & control
KW - Humans
KW - integrated care
KW - Needle-Exchange Programs
KW - opioid use disorder
KW - Opioid-Related Disorders/therapy
KW - Pre-Exposure Prophylaxis/methods
KW - Primary Health Care/methods
AU - K. M. Rich
AU - J. Bia
AU - F. L. Altice
AU - J. Feinberg
A1 - 
AB - PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing continued spread of HIV and HCV. We identified 17 models within primary care (N = 3), HIV specialty care (N = 5), opioid treatment programs (N = 6), transitional clinics (N = 2), and community-based harm reduction programs (N = 1), as well as two emerging models. Key components of such models are the provision of (1) medication-assisted treatment for OUD, (2) HIV and HCV treatment, (3) HIV pre-exposure prophylaxis, and (4) behavioral health services. Research is needed to understand differences in effectiveness between co-located and fully integrated care, combat the deleterious racial and ethnic legacies of the "War on Drugs," and inform the delivery of psychiatric care. Increased access to harm reduction services is crucial.
BT - Current HIV/AIDS reports
C5 - Healthcare Disparities
CP - 3
CY - United States
DO - 10.1007/s11904-018-0396-x
IS - 3
JF - Current HIV/AIDS reports
N2 - PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing continued spread of HIV and HCV. We identified 17 models within primary care (N = 3), HIV specialty care (N = 5), opioid treatment programs (N = 6), transitional clinics (N = 2), and community-based harm reduction programs (N = 1), as well as two emerging models. Key components of such models are the provision of (1) medication-assisted treatment for OUD, (2) HIV and HCV treatment, (3) HIV pre-exposure prophylaxis, and (4) behavioral health services. Research is needed to understand differences in effectiveness between co-located and fully integrated care, combat the deleterious racial and ethnic legacies of the "War on Drugs," and inform the delivery of psychiatric care. Increased access to harm reduction services is crucial.
PP - United States
PY - 2018
SN - 1548-3576; 1548-3568
SP - 266
EP - 275
EP - 
T1 - Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
T2 - Current HIV/AIDS reports
TI - Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
U1 - Healthcare Disparities
U2 - 29774442
U3 - 10.1007/s11904-018-0396-x
VL - 15
VO - 1548-3576; 1548-3568
Y1 - 2018
ER -